AGP Executive Report
Last update: 8 hours agoGLP-1 Ad War: Novo Nordisk sued Eli Lilly in New Jersey, accusing Lilly of deceptive nationwide weight-loss drug advertising by comparing higher-dose results while omitting newer, higher-dose options—setting up a major Lanham Act false-ad fight. Political Money & Targeting: A New York super PAC shifted funding from a challenger to incumbent Rep. Adriano Espaillat after the June primary, with late filings showing how donors from business, labor and advocacy reshuffled support. AI Ads Ambitions: OpenAI reportedly edited a job listing that hinted at building a publisher-facing ad business beyond ChatGPT, while ad-tech firms keep pushing measurement and political targeting suites. Platform/Device Ad Rules: Apple is banning home-service categories from upcoming Maps ads, and LG says it will suspend smart-TV apps that enable TVs as always-on proxy nodes. Media & Local Journalism: Rogers shut down multiple Canadian news radio stations, adding to pressure on local broadcasters. Brand/Compliance: Tabcorp was fined for illegal telemarketing and spam breaches, highlighting tighter scrutiny on gambling marketing. Sports Reach: The World Cup final drew record US audiences, underlining how mainstream soccer is pulling big ad dollars.
Note: AI summary from news headlines; neutral sources weighted more to help reduce bias in the result. Feedback is welcome. Please let us know if you have any comments or suggestions about the AGP Executive Report.
Perspectify News
![<![CDATA[Why Novo Nordisk Sued Eli Lilly Over Zepbound, Mounjaro Ads ]]>](https://2c717466dc25cd7041c9-8eeda6a8ca964cf210ed223dbc947813.ssl.cf2.rackcdn.com/26877768-928491467-51fd9b328adf2f2e73673ce7a0579fc1376748e6-3840x2160-100x56.jpeg)
